Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 42851-42900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06090149
Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients
NARecruiting
30 participants
Started: Mar 1, 2023 · Completed: Nov 30, 2023
4 conditions1 sponsor1 location
NCT06163079
Assisted Reproductive Techniques (ART) With Sperm Donation : an Inclusive Model of ART for All Women
N/ARecruiting
675 participants
Started: Mar 1, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05623956
Proteomics in Small Cell Lung Cancer
N/ARecruiting
50 participants
Started: Mar 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05795634
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
NARecruiting
240 participants
Started: Mar 1, 2023 · Completed: Mar 1, 2029
2 conditions2 sponsors1 location
NCT05755672
On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
N/ARecruiting
100 participants
Started: Mar 1, 2023 · Completed: Mar 31, 2033
5 conditions1 sponsor2 locations
NCT05731414
Outcomes From Remediation and Behavioural Intervention Techniques
NARecruiting
360 participants
Started: Mar 1, 2023 · Completed: Jan 31, 2027
4 conditions5 sponsors2 locations
NCT05881967
Molecular Mechanism Study of Uterine Sarcoma
N/ARecruiting
300 participants
Started: Mar 1, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06155747
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
N/ARecruiting
100 participants
Started: Mar 1, 2023 · Completed: Feb 28, 2028
4 conditions1 sponsor1 location
NCT06079944
Effects of Progressive Resistance Training Combined With Traditional Physical Therapy in Patients With Shoulder Impingement Syndrome
NARecruiting
34 participants
Started: Mar 1, 2023 · Completed: Mar 30, 2024
1 condition1 sponsor1 location
NCT05661097
Clinical Study of Hernia Ring Closure Method in Laparoscopic Abdominal Wall Hernia Repair
NARecruiting
100 participants
Started: Mar 1, 2023 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT05769725
A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer
PHASE2Recruiting
70 participants
Started: Mar 1, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06372548
Rehabilitation Training Games for Children With Amblyopia
NARecruiting
34 participants
Started: Mar 1, 2023 · Completed: Aug 1, 2024
4 conditions1 sponsor1 location
NCT05675878
Confirmation of Diet as a Treatment for Gulf War Illness
PHASE3Recruiting
160 participants
Started: Mar 1, 2023 · Completed: Dec 30, 2025
2 conditions5 sponsors3 locations
NCT05744960
Impact of Financial Incentives
NARecruiting
34 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06103383
Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women
NARecruiting
10 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06161142
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology
N/ARecruiting
60 participants
Started: Feb 28, 2023 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05747196
The Safety and Feasibility of the eLym™ System
NARecruiting
60 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor9 locations
NCT05824832
Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery
PHASE4Recruiting
120 participants
Started: Feb 28, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05821205
Michigan Youth Violence Prevention Center: Building Evidence for Gun Violence Prevention - SafERteens Implementation
NARecruiting
240 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors8 locations
NCT05701306
APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
PHASE1Recruiting
100 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2027
2 conditions2 sponsors3 locations
NCT05697588
Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)
N/ARecruiting
900 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2028
2 conditions8 sponsors1 location
NCT05565534
Diabetes Care for Breast Cancer Patients
NARecruiting
76 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors3 locations
NCT05626491
Electrical Stimulation for the Treatment of Glaucoma
NARecruiting
45 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
2 conditions4 sponsors4 locations
NCT06112470
Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs
N/ARecruiting
20 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT05831345
Intraoperative Methadone for the Prevention of Postoperative Pain
PHASE3Recruiting
80 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05636748
The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke
N/ARecruiting
120 participants
Started: Feb 28, 2023 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT05697601
Predictors of Ovarian Cancer and Endometrial Cancer for Artificial-Intelligence-Based Screening Tools
N/ARecruiting
2,905 participants
Started: Feb 28, 2023 · Completed: Jun 30, 2024
3 conditions2 sponsors1 location
NCT05674786
Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
NARecruiting
8 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2027
9 conditions3 sponsors1 location
NCT05753267
Fenofibrate in Ulcerative Colitis
PHASE2/PHASE3Recruiting
60 participants
Started: Feb 28, 2023 · Completed: Jun 20, 2026
1 condition3 sponsors1 location
NCT05756894
Neurostimulation for Respiratory Function After Spinal Cord Injury
NARecruiting
10 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05651022
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
120 participants
Started: Feb 28, 2023 · Completed: Sep 30, 2027
8 conditions2 sponsors12 locations
NCT05494593
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
PHASE4Recruiting
5 participants
Started: Feb 28, 2023 · Completed: Jul 17, 2028
2 conditions2 sponsors8 locations
NCT06046131
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NARecruiting
3,000 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2039
4 conditions2 sponsors2 locations
NCT05798143
Translational Biomarkers in Accelerated Neuromodulation for Treatment-resistant Depression
NARecruiting
80 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05732272
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
PHASE3Recruiting
500 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05184790
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
N/ARecruiting
300 participants
Started: Feb 28, 2023 · Completed: Jan 31, 2026
9 conditions6 sponsors4 locations
NCT05525260
Limonene for Pulmonary Nodule Chemoprevention
PHASE2Recruiting
160 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06180590
The Efficacy of Vosevi in Treating DAA-experienced Patients
N/ARecruiting
200 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT05803343
Evaluating Additive Effects of Including Canines in Regulating Together
PHASE2Recruiting
240 participants
Started: Feb 28, 2023 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT06826820
Fertility: Infection and Inflammation
N/ARecruiting
800 participants
Started: Feb 28, 2023 · Completed: Dec 20, 2032
1 condition1 sponsor1 location
NCT05744479
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
PHASE4Recruiting
100 participants
Started: Feb 28, 2023 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05691114
Precise Transplantation of Human Amniotic Epithelial Stem Cells Into Lateral Ventricle for Parkinson's Disease
PHASE1Recruiting
18 participants
Started: Feb 28, 2023 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06699017
Effect of Continuous Anterior Chest Compression on Ventilation/Perfusion Ratio and Hemodynamics
NARecruiting
20 participants
Started: Feb 28, 2023 · Completed: May 30, 2025
1 condition1 sponsor1 location
NCT05774938
QoL After Complex Endovascular Aortic Repair
N/ARecruiting
90 participants
Started: Feb 28, 2023 · Completed: Jan 31, 2030
3 conditions1 sponsor1 location
NCT06597838
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
N/ARecruiting
161,876 participants
Started: Feb 28, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05715931
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
PHASE2Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 1, 2028
3 conditions1 sponsor8 locations
NCT06344962
Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection
NARecruiting
40 participants
Started: Feb 28, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05516628
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
PHASE2Recruiting
30 participants
Started: Feb 28, 2023 · Completed: Mar 31, 2027
1 condition14 sponsors6 locations
NCT05709626
PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction
PHASE4Recruiting
2,258 participants
Started: Feb 28, 2023 · Completed: Jan 4, 2028
1 condition2 sponsors1 location
NCT05641493
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
PHASE1/PHASE2Recruiting
49 participants
Started: Feb 28, 2023 · Completed: Feb 27, 2026
1 condition1 sponsor1 location